Campbell Newman Asset Management Buys 24,848 Shares in RadNet

Institutional investor adds to position in medical research company

Apr. 17, 2026 at 7:39am

Got story updates? Submit your updates here. ›

A high-contrast, close-up black and white photograph of the intricate mechanical components and circuitry inside a medical imaging device, conveying the complex technological infrastructure that powers the medical research industry.An institutional investor's sizable new stake in a leading medical imaging company signals confidence in the industry's growth potential.Los Angeles Today

Campbell Newman Asset Management Inc. purchased a new position in shares of RadNet, Inc. (NASDAQ:RDNT) during the 4th quarter, according to a recent SEC filing. The institutional investor bought 24,848 shares of the medical research company's stock, valued at approximately $1.77 million.

Why it matters

This purchase by Campbell Newman Asset Management represents a vote of confidence in RadNet's business and future prospects. As an institutional investor, their decision to add a significant new position in the company could signal positive momentum and growth potential that other investors may want to monitor.

The details

According to the filing, Campbell Newman Asset Management Inc. acquired the 24,848 shares of RadNet during the fourth quarter of 2025. This adds to the institutional investor's position in the medical research company, which operates a network of outpatient diagnostic imaging centers across the United States.

  • The purchase was made during the fourth quarter of 2025, according to the SEC filing.

The players

Campbell Newman Asset Management Inc.

An institutional investment firm that manages assets for clients.

RadNet, Inc.

A leading independent provider of outpatient diagnostic imaging services in the United States, operating a nationwide network of imaging centers.

Got photos? Submit your photos here. ›

The takeaway

This investment by Campbell Newman Asset Management suggests the firm sees strong growth potential in RadNet's business model and market position. As an institutional investor, their decision to take a sizable new stake in the company could signal broader confidence in the medical imaging sector and RadNet's ability to capitalize on industry trends.